Episode #7: When Triglycerides Rise and HDL Falls

By now, the system is visible.

Particles are being produced.
Particles are being cleared.

And the number in circulation reflects the balance between those two forces.


Up to this point, it’s been useful to think about each side separately.

Production explains how particles enter the system.
Clearance explains how they leave.


But in real-world biology, these processes don’t operate in isolation.

They often shift together.


When that happens, the effect is not subtle.

It compounds.


More particles are entering circulation.
Fewer particles are being removed.

The system is being pushed in the same direction from both sides.


This pattern is not rare.

It shows up every day.


It’s often described using familiar terms:

Elevated triglycerides.
Low HDL cholesterol.
Central adiposity.
Insulin resistance.

Each of these findings is typically considered on its own.


But together, they reflect something more coordinated.

A shift in the system itself.


From a particle perspective, what’s happening is more direct.

Production is increasing.

The liver is generating more triglyceride-rich particles, adding to the pool of circulating ApoB-containing particles.


At the same time, clearance becomes less efficient.

Particles remain in circulation longer, extending their exposure.


The result is predictable.

Particle number rises.
Exposure accumulates.


What makes this pattern difficult to recognize is how it appears on standard testing.

LDL-C may not be dramatically elevated.
Sometimes it appears only modestly increased.


From a cholesterol perspective, the system can look relatively stable.


But underneath that, the dynamics are different.

ApoB is often elevated.

Particle number is higher than the cholesterol measurement suggests.


This is another form of discordance.

But here, it reflects something deeper than measurement alone.

It reflects the behavior of the system itself.


This helps explain a familiar clinical observation.

Some individuals develop cardiovascular disease despite LDL-C levels that appear “acceptable.”


Not because the model is wrong.

But because the measurement does not fully capture what is happening.


From a system perspective, risk is not defined by a single value.

It is defined by sustained exposure over time.


And that exposure is being driven from both sides:

  • increased production
  • reduced clearance

This changes how the problem is understood.

Not as a single abnormality.

But as a system that has shifted out of balance.


Which leads to a different kind of question.

If both sides of the system are contributing…

how do you make sense of it?


Continue reading → A Simple Way to Map the System

Or start here - The LIV System

Back to blog